Novo Nordisk Russia Contacts Site Map Search About company Products and services Defeating diabetes Patients Press center Career Contacts About company Novo Nordisk worldwide Novo Nordisk in Russia History of Novo Nordisk Novo Nordisk Way Changing Diabetes® Our responsibility Areas of activity Diabetes treatment Hemophilia treatment Growth hormone therapy Diabetes mellitus treatment Diabetes mellitus is a chronic disease caused by insufficient production of insulin in the human body and / or a reduced ability of the cells in the body to use insulin. In healthy people, insulin is produced by special cells in the pancreas, which also produces other substances that aid in the processing of food. Insulin is the most important hormone in the human body that regulates blood sugar (blood glucose) levels. In addition, insulin affects fat metabolism. Diabetes mellitus is a serious disease that affects various organs such as the eyes, kidneys, nerves, heart and legs. However, the use of modern methods of treatment, as well as the correct observance of all the recommendations of the attending physician, will avoid these complications. Type 1 diabetes mellitus is usually diagnosed in children and young people under 30 years of age. It develops as a result of the death of the beta cells of the pancreas, which produce insulin. If diabetes has already developed, then it is impossible to restore the cells that produce insulin. Therefore, daily injections of insulin are life-saving therapy for someone with type 1 diabetes. Type 2 diabetes mellitus is the result of both progressive dysfunction of beta cells and a decrease in the ability of cells in the human body to use insulin. The latter phenomenon is known as insulin resistance. Type 2 diabetes is often hereditary, but obesity and a sedentary lifestyle are the most significant risk factors for the development of this disease. Novo Nordisk offers the largest selection of diabetes medications in the pharmaceutical industry, including short and long acting insulins, as well as a full portfolio of insulin analogues. In addition, Novo Nordisk produces the widest range of convenient insulin delivery devices. All this makes Novo Nordisk a leader in the treatment of diabetes mellitus. To the top of the page NovoNordisk.com Information and confidentiality Last modified: 2009-09-15 © Novo Nordisk A / S 2015